CV: Yousef Mohammad MD, MSc

Yousef Mohammad, MD, MSc
Assistant Professor
Director, Stroke Fellowship Program
Department of Neurology
College of Medicine
The Ohio State University

Practice Address:

403 Means Hall
1654 Upham Drive
Columbus, Ohio 43210
614-293-4974

Education:

Sept. 85 – June 89. American University Of Beirut, Faculty of Medicine: Awarded the Doctor of Medicine Degree
Oct. 84 - June 86. American University Of Beirut, Faculty of Medicine: Awarded Master of Science Degree in Physiology
Oct. 80 - June 83. American University Of Beirut, Faculty of Health Sciences: Awarded BS Degree, July 1983
ECFMG Certification. Educational Commission for Foreign Medical Graduates

Post Graduate Training:

Emory University School of Medicine (Atlanta, Georgia) Department of Neurology Stroke Fellowship (July 97 – June 99)
Wayne State University (Detroit, Michigan), Department of Neurology Sleep Disorder Fellowship (Jan 97 - June 97)
Wayne State University (Detroit, Michigan), Department of Neurology
PGY II (Jan 94 - Dec 94)
PGY III (Jan 95 - Dec 95)
PGY IV (Jan 96 - Dec 96)
Good Samaritan Hospital/ Johns Hopkins Hospital (Baltimore, Maryland) PGY I- Internal Medicine (Jan 93 - Dec 93)
American University Of Beirut-Medical Center, Dept. Of Family Medicine
PGY II (July 90 - June 91)
PGY III (July 91 – June 92)
Chief Resident (July 92 – Dec 92)
American University of Beirut-Medical Center (Beirut- Lebanon) Rotating Intern (July 89- June 90)

Licensure or Certification:

Diplomate of the American Board of Psychiatry and Neurology, Inc., a member Board of the American Board of Medical Specialties. June 2004-2014.
Ohio State Medical Board License Number: (Active)

Associations:

American Academy of Neurology
Society for Neuroscience
American Heart Association Stroke Council
Mississippi Neurological Society Association.
American Headache Society
Neuroepidemiology Section of the American Academy of Neurology
Stroke Section of the American Academy of Neurology
Neuroimaging Section of the American Academy of Neurology
American Society of Neuroimaging
International Brain Research Organization
National Arab American Medical

Affiliations:

2001-present. Assistant Professor and Director of the Stroke Fellowship Program. Departmant of Neurology, Division of Stroke and Cerebrovascular Diseases, Ohio State University Medical Center
1999-2001. Assistant Professor of Neurology and Director of Acute Stroke Unit. The University of Mississippi Medical Center, Jackson, Mississippi

Partial List of Publications:

Featured in Article: “Stroke patients receive better care when they arrive via ambulance”. Ladies’ Home Journal. May 2006.
Featured by OSU Medical Center This Week (medmail@osumc.edu) under the Discovery Section: “Stroke Patients Benefits From Mode of Transportation”. March 6, 2006.
Featured in Article: “Stroke patients arriving by ambulance are treated differently than walk-ins” Neurology Reviews: Clinical Trends & News in Neurology. Volume 14 Number 3, March 2006.
Mohammad YM. Low Use of t-PA for Acute Ischemic Stroke Nationwide: A Wake-up Call. Comment on Qureshi AI et al. Thrombolysis for ischemic stroke in the United States: Data from National Hospital Discharge Survey 1999-2001. Neurosurgery 2005 Oct; 57:647-54. Journal Watch Neurology, March 2006.
Featured by Los Angeles Times: Stroke victims: go to the ER, stat. Based on the Abstract “Mode of arrival in patients presenting with stroke to the emergency room in the United States”. February 20, 2006.
Featured by WNBC 4 News: “Calling Ambulance Better For Stroke Victims”. February 17, 2006. Columbus, Ohio.
Featured by the American Heart/Stroke Association Web Site, under section What’s new: “Stroke patients arriving to ER by ambulance treated differently than walk-ins. February 16, 2006.
Featured by U.S.News & World Report: “Study: Ambulance Brings Faster Stroke Care”. February 16, 2006.
Featured by MSNBC TV Station: “Stroke care faster when ambulance called. Driving patient to emergency room yourself may slow down treatment” February 16, 2006.
Featured by News 14 Carolina: “Migraine Zapper”. January10, 2006. Charlotte, NC. Featured by InCirculation.net: “Ambulance arrivals get faster stroke care” February 11, 2006.
Featured by WNDU News Center 16: “Ending hours of suffering for migraine sufferers”. February 6, 2006. South Bend, Indiana.
Featured by WOSU Stations: Acute Stroke Treatment and effect of mode of arrival to the emergency on stroke management”. February 3rd, 2006. Columbus, Ohio.
Featured by ABC 7 KGO-TV/DT: “Zapping Away Migraine Headaches”. February 3, 2006. San Francisco, California.
Featured by WCTV Eyewitness News: “Medical Minute: Migraine Zapper” February 2006. Ohio.
Featured by NBC 10: “You could zap your migraine away” January 13, 2006.
Mohammad YM. Quantitation of Regional Cerebral Blood Flow: The Next Chapter in Digital Subtraction Angiography. An editorial Journal of Neuroimaging 2006;16: 179-180.
Kasner S, Chimowitz M, Lynn M, et al. for the WASID Investigators. Predictors of Ischemic Stroke in the Territory of a Symptomatic Intracranial Stenosis. Circulation 2006; 113:555-563
Featured by American RSD Hope: “Medical treatment: Migraine Zapper”. December 21, 2005.
Featured by 7 News Boston: “Migraine gun”. December 8, 2oo5. Boston, Massachusetts
Interviewed by the American Heart Association reporters in-regard to my Abstract” Mode of Arrival in Patients Presenting to the Emergency Room with Stroke in the United States” December 5th 2005. Columbus, Ohio.
Featured by the Ivanhoe TV Station: “Migraine Headache and Transcranial Magnetic Stimulation”. October 27th 2005. Columbus, Ohio.
Featured in article “Transcranial Magnetic Stimulation for Migraine Headache”. Columbus Post. Sept 2005.
Qureshi AI, Suri MFK, Kirmani JF, Divani AA. Mohammad YM, Is Pre-hypertension a Risk Factor for Cardiovascular Diseases. Stroke. 2005 Sept; 36(9): 1859-63. The Manuscript was Selected by the American Heart Association to be Among the 10 Best Research Advances for 2005
Chritofiridis G, Mohammad YM, Kehagias D, Avutu B, Slivka AP. Angiographic Assessment of Pial Collaterals as a Prognostic Indicator Following Intra-Arterial Thrombolysis for Acute Ischemic Stroke. American Journal of Neuroradiology. 26:1789-1797, August 2005.
Featured by 610 WTVN NewsRadio: “Transcranial Magnetic Stimulation for Acute Migraine Headache with and Without Aura”. July 13th. Columbus, Ohio.
Featured by the WOSU Stations.: “Transcranial Magnetic Stimulation for Acute Migarine Headache with and without aura”. June 9th, 2005. Columbus, Ohio.
Featured in article “Transcranial Magnetic Stimulation for Migraine Headache with Aura”. Business First. June 2005.
Featured by NBC4 TV Station: “magnet May Mend Migraines”. June 2005. Los Angeles, California.
Featured by Ohio State University/VNR: “Transcranial Magnetic Stimulation for Acute Migraine Headache with and Without Aura”. May 6th, 2005. Columbus, Ohio.
Comparison of Warfarin and Aspirin for Symptomatic Intracranial Stenosis. Marc I. Chimowitz M.B.., Ch.B., Michael J. Lynn, M.S., Harriet-Smith, RN., Barney J. Stern, M.D., Vicki S. Hertzberg, Ph.D., Michael R. Frankel, M.D., Steven R. Levine., Seemant Chaturvedi, M.D., Scott E. Kasner. M.D., Curtis G. Benesh, M.D., Cathy A. Sila, M.D., Tudor G. Jovin, M.D., Jose G. Romano, M.D., for the Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators NEJM. Volume 352: 1305-1316. March 31, 2005.
Featured in Article “ Uncontrolled Diabetes is Associated with Impaired Cognitive Function” Prevention Magazine. March 2005.
Featured by local Fox T.V. station: “Transcranial Magnetic Stimulation for Acute Migraine Headache”. February 21, 2005. Columbus, Ohio.
Featured by Channel 6 local T.V. station: “Transcarnial Magnetic Stimulation for Acute Migraine Headache”. February 21, 2005. Columbus, Ohio.
Featured by Tampa Bays 10 News-WTSP: “Stroke care is quicker when victims go to the ER by ambulance, not car. February 17, 2005. Tampa, Florida.
Featured in Article “Transcarnial Magnetic Stimulation for Migraine Headache” Prevention Magazine, February 2005.
Featured by local NBC T.V. station: “Transcranial Magnetic Stimulation for Acute Migarine Headache”. January 24, 2005. Columbus, Ohio.
Clairmont A, Nash S, Mohammad YM: Electrodiagnostic Medicine IV: Case Studies. In: Braddom R. Physical Medicine and Rehabilitation 4th Edition. Elsevier. United Kingdom, 2005.
Qureshi AI, Mohammad YM, Yahia AM, Suarez JI, Siddiqui AM, Kirmani JF, Suri MFK, Kolb J, Zaidat OO, Xavier AR. A Prospective Multicenter Study to evaluate the Feasibility and Safety of Aggressive Antihypertensive Treatment in Patients with Acute Intracerebral Hemorrhage. J Intensive Care Med 2005;20:34-42.
Zaidat OO, Slivka AP, Mohammad YM, Graffagnino C, Smith TP, Enterline DS, Christoforidis GA, Alexander MJ, Landis D, Suarez JI. Intra-arterial Thrombolytic Therapy in Peri-Coronary Angiography Ischemic Stroke. Stroke. 2005;36:1083-1084.
Chen DT, Worrall BB, Brown Rd, Brott TG, Kissela BM, Olson TS, Rich SS, Meschia JF, for the SWISS Investigators. The Impact of Privacy Protections on Recruitment in a Multicenter Stroke Genetics Study. Neurology 2005; 64:721-724.
Mohammad YM, Divani AA, Kirmani JF, Lane PH, Qureshi AI. Acute Treatment for Stroke in 2004. Journal of Emergency Radiology. 2004 Dec; 11(2): 83-6.
Featured in Article “Transcranial Magnetic Stimulation for Migraine Headache” National Post Newspaper in Canada. August 2004.
Mohammad YM, Klinger S, Divani AA, Kirmani JF, Qureshi AI. Types and Etiology of Stroke. Endovascular Today. May 2004: 31-35.
Mohammad YM: Cardioembolic strokes. In: Lynn DJ, Newton HB, Rae-Grant A. The 5 minute Neurology Consult. William & Wilkins. Baltimore, 2004.
Mohammad YM: Ischemic Stroke. In: Lynn DJ, Newton HB, Rae-Grant A. The 5 Minute Neurology Consult. William & Wilkins. Baltimore, 2004.
Mohammad YM: Cerebral Venous Thrombosis. In Lynn DJ, Newton HB, Rae-Grant A. The 5 Minute Neurology Consult. William & Wilkins.Baltimore, 2004.
Mohammad YM: Transient Ischemic Attack. In Lynn DJ, Newton HB, Rae-Grant A. The 5 Minute Neurology Consult. William & Wilkins. Baltimore, 2004.
Mohammad YM, Xavier AR, Christoforidis GA, Bourekas EC, Slivka AP. Qureshi Grading Scheme for Angiographic Occlusions Strongly Correlates with the Initial Severity and in-hospital Outcome of Acute Ischemic Stroke. Journal of Neuroimaging. 14:235-241, 2004.
Qureshi AI, Choudhry MA, Mohammad YM, Chua HC, Yahia AM, Ulatowski JA, Krendel DA, Leshner RT. Respiratory Failure as a First Presentation of Myasthenia Gravis. Med Sci Monit 2004; 10(12): CR684-689.
Qureshi AI, Suri MK, Ziai W, Yahia AM, Mohammad,YM, Sen S, Agarwal P, Zaidat OO, Suarez JI, Wityk RJ. Stroke Free Survival and its Determinants in Patients with Symptomatic VertebroBasilar Stenosis. A Multicenter Study. Neurosurgery 2003=3 May; 52(5): 1033-9; discussion 1039-40.
Qureshi AI, Suarez JI, Yahia AM, MohammadYM, Uzen G, Suri MFK, Zaidat OO, Ayata C, Ali Z, Weityk R. Timing of Neurological Deterioration in Massive Middle Cerebral Artery Infarction. A Multi-Center review. Critical Care Medicine. 31: 272-277, 2003.
The Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Design, Progress and Challenges of a Double Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis . Neuroepidemiology Journal 2003; 22:106-117.
S. Ruland, DO; R. Raman, PhD; S. Chaturvedi, MD; S. Leurgans, PhD; and P.B. Gorelick, MD, for the AAASPS Investigators. Awareness, Treatment, and Control of Vascular Risk Factors in African Americans with Stroke. Neurology 2003; 60:64-68.
Gorelick PB, Richardson D, Kelly M, Ruland S, Hung E, Harris Y, Kittner S, Leurgans S, for the African American Antiplatelet Stroke Prevention Study (AAASPS) Investigators. Aspirin and Ticlopidine for Prevention of Recurrent Stroke in Black Patients: A Randomized Trial. JAMA 2003; 289:2947-2957.
Hanel RA, Xavier AR, Mohammad YM, Kirmani JF, Yahia AM, Qureshi AI. Outcome Following Intracerebral Hemorrhage and Subarachnoid Hemorrhage. Neurological Research Journal. Vol 24, Supplement 1: S58-S62, 2002.
Qureshi AI, Suri MFK, Mohammad, YM, Guterman LR, Hopkins LN. Isolated and Borderline Isolated Systolic Hypertension Relative to Long-Term Risk and Type of Stroke: A 20-Year Follow-up of the National Health and Nutrition Survey. Stroke. 33: 2781-2788, 2002.
1. Qureshi AI, Mohammad YM, Suri MFK, Braimah J, Janardhan V, Guterman LR, Hopkins NL, Frankel MR. Cocaine Use and Hypertension are Major Risk Factors for Intracerebral Hemorrhage in Young African Americans. Ethnicity and Disease Journal. Vol 11:311-319, Spring/Summer 2001.
Benesch CG, Chimowitz MI, for the WASID Investigators. Best Treatment for Intracranial Arterial Stenosis. Neurology. 55:465-466, August 2000.
Qureshi AI, Mohammad YM, Yahia AM, Luft AR, Sharma M, Tamargo RJ, Frankel MR. Ischemic Events Associated with Unruptured Intracranial Aneurysms: Multicenter Clinical Study and Review of the Literature. Neurosurgery. 46(2):282-290, February 2000.
Clairmont A, Mohammad YM, Elsheikh B. Evaluation of a Patient with Suspected Myopathy in “Johnson’s Practical Electromyography” Book. In Press.
Warrall BB, Johnston KG, Kongable G, Hung E, Richardson D, Gorelick PB, for the AAASPS Investigators. Stroke in African American Women: An Interim Report from the African-American Antiplatelet Stroke Prevention Study. Submitted to JAMA Special Issue on Women’s Health.
Mohammad YM, Christoforidis GA, Bourekas EC, Shah R, Slivka AP. Qureshi Grading Scheme Predicts Subsequent Volume of Brain Infarction Following Intra-arterial Thrombolysis in Patients with acute Ischemic stroke. Submitted to the Journal of Neuroimagimng.
Mohammaad YM, Divani AA, Jradi HA, Hoonjan Amardeep, Kirmani JF, Qureshi AI. Primary Stroke Center: Basic Components and Recommendations. Southern Medical Journal. In Press.
Christoforidis GA, Mohammad YM, Slivka AP. Arteriographic Demonstration of Slow Antegrade Opacification Distal to a Cerebrovascular Thromboembolic Occlusion Site as a Favorable Indicator for Intraarterial Thrombolysis. American Journal of Neuroradiology. In press.
Ovbiagele B, Saver JL, Lynn M, Chimowitz M, for the WASID Study Group. Impact of Metabolic Syndrome on Prognosis of Symptomatic Intracranial Atherosclerosis. Neurology Journal. In Press.

Research:

Clinical Co-Investigator Does Aprotinin Prevent Stroke (DAPS) Trial: A Multicenter, Randomized, Double-Blind Study in High Risk Cardiac Surgery. Sponsored by NIH. 2006-Present.
Principle Investigator Treatment of the Aura Phase of Migraine Headache by Non-Invasive Portable Transcranial Magnetic Stimulation (TMS) System. A Randomized, double-blind placebo controlled multi-center study. Sponsored by Neuralieve, Inc. 2006-Present.
Principle Investigator A Phase II Randomized, Double-Blind, Parallel Group, Placebo controlled study to evaluate the Effectiveness of Masking of a Placebo Device Compared to Non-Invasive, Non-Repetitive Transcranial (TMS) in Asymptomatic Migraineurs with and Without a History of Visual Aura. Sponsored by Neuralieve, Inc. 2006-Present.
Co-Investigator CAROTID OCCLUSION SURGERY STUDY (COSS). A multi-center study sponsored by NIH. 2005-Present.
Principal Investigator Telemedicine by a Stroke Neurologist is Superior to Bedside Emergency Room Physicians in the Assessment of NIHSS. Funded by Genentech, Inc. Pharmaceutical Company. 2005-Present
Co-Investigator, A post-approval study of the guidant carotid scent systems and embolic protection systems, (Carotid RX ACCULINK/ACCUNET Post-Approval Trial to Uncover Unanticipated or Rare Events-“CAPTURE”) Sponsored by Guidant Corporation. 2005-Present.
Clinical Co-Investigator DIAS-II (Desmoteplase (INN) in Acute Ischemic Stroke: Phase III. A prospective, randomized, double-blind, placebo-controlled, single bolus, multi-national, multi-center, parallel group, dose ranging study of desmoteplase (INN) in the indication of acute ischemic stroke. Sponsored by Forest Research Institute. 2005- present.
Principle Investigator Treatment of the Aura Phase of Migraine Headache by Non-Invasive Portable Transcranial Magnetic Stimulation (TMS) System. An open label study. Sponsored by Neuralieve, Inc. 2005-2006.
Principle Investigator Treatment of the Aura Phase of Migraine Headache by Non-Invasive Portable quasielliptica coil Transcranial Magnetic Stimulation (TMS) System. An open label study. Sponsored by Neuralieve, Inc. 2005-Present.
Principal Investigator Anti-hypertensive Treatment of Acute Cerebral Hemorrhage. A multi-center study sponsored by NIH. 1 RO1 NS044976-01A2 2004-Present.
Co-Investigator Prevention Regimen for Effectively Avoiding Second Stroke (PRoFESS). A Multi-center, Multi-national trial sponsored by Boehringer Ingelheim. 2004-Present.
Clinical Co-Investigator SPS3: Secondary Prevention of Small Subcortical Strokes. A multicenter trial sponsored by NIH/NINDS and The University of Texas Health Sciences Center, San Antonio, TX 2003- Present
Clinical Co-Investigator SWISS: Siblings with Ischemic Stroke Study Sponsored by NIH and MPACT (Mayo Physician’s Alliance for Clinical Trials) 2003- Present
Clinical Investigator RESPECT: Randomized Evaluation of Recurrent Stroke comparing PFO Closure to Established Current Standard of Care Treatment. A Multi Center Study, Sponsored by AGA Medical Corporation. 2003-Present.
Clinical Co-Investigator VITATOPS: Vitamins to Prevent Stroke Study. A multi-center trial sponsored by the Royal Perth Hospital of Australia 2003- Present
Clinical Investigator Motor Map Plasticity in Constraint Therapy for Stroke, Sponsored by NIH. NIHCHD. 1RO1HD/NS40984-01A1. 2002- 2005.
Principal Investigator Treatment of the Aura Phase of Migraine Headache by Non-Invasive Transcranial Magnetic Stimulation (TMS). A Multi Center Study, Sponsored by NeuraLieve, Inc. 2002-Present.
Co-Investigator Study of Migraine Headache. The Relationship of Reproductive Hormones, Headache Activity, and Menstrual Distress: Migraine Patients vs. Headache-Free Controls. A Grant ($20,000) Funded by the American Headache Society/Merck Migraine and Women’s Award. 2000-2001.
Clinical Investigator Spasticity Treatment: A Preliminary, Phase I, Open-Label, Safety and Dose Escalation Study of Botulinium Toxin Type B in Patients with Dysfunctional Elbow Flexor Spasticity in Acute and Chronic Acquired Brain Injury. Funded by Elan Pharmaceuticals. 2000- 2001
Principal Investigator Secondary Stroke Prevention: Warfarin vs. Aspirin for Symptomatic Intracranial Disease. (WASID) Study- A 5 Year Multi-Center Clinical Trial, Sponsored by NIH. 1999- 2003
Clinical Investigator NeuroImaging Study: Stroke Outcomes and NeuroImaging of Intracranial Atherosclerosis. (SONIA) Study. Sponsored by NIH 1999-2003.
Sub- Investigator Acute Stroke Study: Citicoline for Acute Ischemic Stroke. A study funded by Interneuron Pharmaceuticals. 1999-2000.
Mississippi Stroke Screening Training Program 2000 for Eliza Pillars Registered Nurses Association Stroke Screenings in African-American Churches, Stroke Belt Consortium

Grants:

Prime Minister Hariri’s Foundation Grant: Educational tuition and fees paid in full for the entire Graduate and Medical school years at the American University of Beirut.

Partial List of Presentations:

Mohammad YM, Hughes G, Nkrumah M, Fischell S, Fischell R, Ruppel P, Schweiger J. Self-administered Transcranial Magnetic Stimulation (TMS), during the aura phase, improves and aborts migraine headache. Accepted for Presentation at the 10th Congress of the European Federation of Neurological Sciences in Glasgow, United Kingdom. September 2-5, 2006.
Mohammad YM, Kothari R, Hughes G, Nkrumah M, Fischell S, Fischell R, Schweiger J, Ruppel PL. Transcranial Magnetic Stimulation (TMS) relieves migraine headache. Accepted for Presentation at the 10th Congress of the European Federation of Neurological Sciences in Glasgow, United Kingdom. September 2-5, 2006.
Mohammad YM, Hughes G, Nkrumah M, Fischell S, Fischell R, Ruppel P, Schweiger J. Self-administered Transcranial Magnetic Stimulation (TMS), during the aura phase, improves and aborts migraine headache. Presented at the 48th Annual Meeting of the American Headache Society in Los Angeles, California. June 22-25, 2006.
Mohammad YM, Kothari R, Hughes G, Nkrumah M, Fischell S, Fischell R, Schweiger J, Ruppel PL. Transcranial Magnetic Stimulation (TMS) relieves migraine headache. Presented at the 48th Annual Meeting of the American Headache Society in Los Angeles, California. June 22-25, 2006.
Lacunar Syndromes and Vasculopathies, a Session of the Annual Vascular Neurology Review Course. Newark, NJ. June 2-4, 2006.
Stroke Update in 2006. National Arab American Medical Association (NAAMA). Columbus, Ohio. May 12th, 2006.
Acute Stroke Update. 2006 EMS Conference. Delaware, Ohio. May 5th, 2006.
Upchurch TP, Cotsonis GA, Lynn MJ, Sila CA, Romano JG, Katzan I, Woolfenden HA, Slivka A, Chimowotz MI, for the WASID Trial Investigators. Outcome Following Interruption of Antithrombotic Therapy for Symptomatic Intracranial Atherostenosis. Presented at the 58th Annual Meeting of the American Academy of Neurology in San Diego, California, April 2006.
Mohammad YM, Nasar A, Suri FK, Qureshi AI. A Prospective 1 year outcome study in patients with intracranial hemorrhage related to tissue plasminogen activator administration. Presented at the 58th Annual Meeting of the American Academy of Neurology in San Diego, California, April 2006.
Mahmood MA, Chaturvedi S, Mohammad YM, Lynn M, Chimowitz MI, for the WASID Study Group. Extracranial Carotid Atherosclerosis in Patients with Intracranial Stenosis: Predictors and Influence on Prognosis. Presented at the 58th Annual Meeting of the American Academy of Neurology in San Diego, California, April 2006.
Christoforidis GA, Mohammad YM, Yang M, Caragine L, Slivka AP. Effect of Pial Collateral Formation on Hemorrhage Rate and Hemorrhage Volume. Presented at the XVII Symposium Neuroradiologicum meeting. Adelaide, Australia. March 19-24, 2006.
Christoforidis GA, Mohammad YM, Yang M, Caragine L, Slivka AP. Influence of Extent of Recanalization on Clinical Outcome and Infarct Volume Following Intra-arterial Thrombolysis. Presented at the XVII Symposium Neuroradiologicum meeting. Adelaide, Australia. March 19-24, 2006.
Conducted the Neurology Journal Club. Norman Allen Library. Columbus, Ohio. March 9, 2006.
Janjua N, Nasar A, Suri FK, Mohammad YM, Kirmani JF, Ezzedine, M, Qureshi AI. The Financial Burden of Pediatric Stroke Cannot be Undermined in United States. Presented at the Ninth Joint Annual Meeting of the AANS/CNS Cerebrovascular Section and the ASITN. February 17-20, 2006.
Mohammad YM, Nasar A, Shekhtman V, Harris-Lane P, Ezzeddine MA, Suri FK. Mode of Arrival in Patients Presenting to the Emergency Room with Stroke in the United States. Presented at the Ninth Joint Annual Meeting of the AANS/CNS Cerebrovascular Section and the ASITN. February 17-20, 2006.
Mohammad YM, Nasar A, Jradi HA, Suri FK, Ezzeddine MA. Hospitalization for Simultaneous Carotid Endarterectomy and Coronary Artery Bypass Grafting in United States is Associated with Worse Outcomes. Presented at the Ninth Joint Annual Meeting of the AANS/CNS Cerebrovascular Section and the ASITN. February 17-20, 2006.
Mohammad YM, Christoforidis GA, Slivka AP, Nkrumah M, Atieh. J. Prognostic Value of the Hyperdense Middle Cerebral Artery Sign in Patients Treated With Intra-arterial Thrombolysis. Presented at the Ninth Joint Annual Meeting of the AANS/CNS Cerebrovascular Section and the ASITN. February 17-20, 2006.
Mohammad YM, Christoforidis GA, Bourkas EC, Slivka AP, Jradi HA, Shekhtman V. Hyperdense MCA Sign and Recanalization Rate in Patients Treated With Intra-arterial Thrombolysis. Presented at the Ninth Joint Annual Meeting of the AANS/CNS Cerebrovascular Section and the ASITN. February 17-20, 2006.
Christoforidis GA, Mohammad YM, Yang M, Caragine L, Slivka AP. Effect of Pial Collateral Formation on Hemorrhage Rate and Hemorrhage Volume. Presented at the Ninth Joint Annual Meeting of the AANS/CNS Cerebrovascular Section and the ASITN. February 17-20, 2006.
Christoforidis GA, Mohammad YM, Yang M, Caragine L, Slivka AP. Influence of Extent of Recanalization on Clinical Outcome and Infarct Volume Following Intra-arterial Thrombolysis. Presented at the Ninth Joint Annual Meeting of the AANS/CNS Cerebrovascular Section and the ASITN. February 17-20, 2006.
Christoforidis GA, Yang M, Mohammad YM, Slivka AP. Effect of Hypercarbia on Infarct Volume in Experimental Stroke. Presented and received Poster Award at the Ninth Joint Annual Meeting of the AANS/CNS Cerebrovascular Section and the ASITN. February 17-20, 2006
Janjua N, Nasar A, Suri FK, Mohammad YM, Kirmani JF, Ezzedine, M, Qureshi AI. The Financial Burden of Pediatric Stroke Cannot be Undermined in United States. Presented at the 31st American Stroke Association International Stroke Conference in Kissimmee, Florida. February 16-18, 2006.
Ovbiagele B, Lynn MJ, Saver JL, Chimowitz MI, for the WASID Study Group. Elevated White Blood Count and Increased Risk for Stroke and Vascular Death in Patients with Symptomatic Intracranial Disease. Presented at the 31st American Stroke Association International Stroke Conference in Kissimmee, Florida. February 16-18, 2006.
Famakin BM, Lynn MJ, George MG, Chimowitz MI, for the WASID Investigators. Causes and Severity of Stroke in Patients with Symptomatic Intracranial Stenosis. Presented at the 31st American Stroke Association International Stroke Conference in Kissimmee, Florida. February 16-18, 2006.
Kasner SE, Lynn MJ, Jackson BP, Pullicino PM, Chimowitz MI, The WASID Trial Investigators. Echocardiographic Findings Patients with Symptomatic Intracranial Stenosis. Presented at the 31st American Stroke Association International Stroke Conference in Kissimmee, Florida. February 16-18, 2006.
Waddy S, Cotsonis G, Lynn MJ, Frankel M, Chaturvedi S, Chimowitz M, for the WASID Investigators. Racial Diffeences in Risk Factor management in the Wasrfarin vs. Aspirin for Symptomatic Intracranial Disease Trial. Presented at the 31st American Stroke Association International Stroke Conference in Kissimmee, Florida. February 16-18, 2006.
Maidan L, Lynn M, Cotsonis G, Upchurch T, Levine S, Romano J, Chimowitz M, for the WASID Investigators. Intracranial Stenosis, “Failure” of Antithrombotic Therapy. And Risk of Stroke. Presented at the 31st American Stroke Association International Stroke Conference in Kissimmee, Florida. February 16-18, 2006.
Makki AA, Turan TN, Cotsonis GA, Lynn MI, Chimowitz MI, for the WASID Trial Investigators. Risk Factors for Severe Intracranial Arterial Stenosis. Presented at the 31st American Stroke Association International Stroke Conference in Kissimmee, Florida. February 16-18, 2006.
Johnston KC, Lynn MJ, Gaines KJ, Smith KJ, Chimowitz MI, for the WASID Investigators. Characterization of the Hemorrhage Subjects in the Warfarin vs Aspirin in Symptomatic Intracranial Disease (WASID) trial. Presented at the 31st American Stroke Association International Stroke Conference in Kissimmee, Florida. February 16-18, 2006.
Chaturvedi S, Lynn M, Bruno A, Mohammad YM, Wityk R Chimowitz MI, for the WASID Study Group. Effects of Statins on Major Vascular Events in Patients with Symptomatic Intracranial Stenosis. Presented at the 31st American Stroke Association International Stroke Conference in Kissimmee, Florida. February 16-18, 2006.
Mohammad YM, Nasar A, Shekhtman V, Harris-Lane P, Ezzeddine MA, Suri FK. Mode of Arrival in Patients Presenting to the Emergency Room with Stroke in the United States. Presented at the 31st American Stroke Association International Stroke Conference in Kissimmee, Florida. February 16-18, 2006.
Mohammad YM, Nasar A, Jradi HA, Suri FK, Ezzeddine MA. Hospitalization for Simultaneous Carotid Endarterectomy and Coronary Artery Bypass Grafting in United States is Associated with Worse Outcomes. Presented at the 31st American Stroke Association International Stroke Conference in Kissimmee, Florida. February 16-18, 2006.
Christoforidis GA, Yang M, Epstein CR, Abduljalil A, Mohammad YM. Newton HB. High Resolution Ultrahigh Field Strength Gradient Echo MRI of the Brain in Normal and Pathologic States. Presented at the Annual Meeting of the RSNA in Chicago, Illinois. Nov 27-Dec 2, 2005.
Secondary Stroke Prevention in 2005. Wright Patterson Air Force Base Hospital. Dayton, Ohio. October 16, 2005.
Conducted the Neurology Journal Club. Norman Allen Library. Columbus, Ohio. October 13, 2005.
Headache and Migraines`. OSU East Campus Hospital Ground Round, OSU MedNet 21 Webcasts. Columbus, Ohio. September 9, 2005.
Migraine: Pathophysiology, Treatment, and Prevention. OSU Webcast which serve as a CME provider for 6,000 physician from over thirty countries. Columbus, Ohio. June 10, 2005.
Neurology Section for the family medicine board review course. Columbus, Ohio. May 31st 2005.
Ovbiagele B, Saver JL, Cotsonis G, Lynn M, Chimowitz M, for The WASID Study Group. The Metabolic Syndrome is Highly Prevalent and Increases the Risk of Recurrent Vascular Events Among Individuals with Symptomatic Intracranial Atherosclerotic Disease. Presented at the 57th Annual Meeting of the American Academy of Neurology Meeting in Miami, Florida, May 2005.
Chaturvedi S, Lynn M, Frankel M, Kasner SE, Romano J, Cotsonis G, Chimowitz M, for the WASID Study Group. Influence of Risk Factors on Subsequent Vascular Events in Patients with Symptomatic Intracranial Stenosis. Presented at the 57th Annual Meeting of the American Academy of Neurology in Mialmi, Florida. May 2005.
Mohammad YM, Qureshi AI, Nasar A, Siddiqui AU, Ebrahimi A, Michael SK, Divani AA. High Prevalence of Dizziness Among Adults in the United States: Results from the National Health and Nutrition Examination Survey 1999-2000. Presented at the 57th Annual Meeting of the American Academy of Neurology in Miami, Florida. May 2005.
Mohammad YM, Christoforidis GA, Atieh JM, Bourekas EC, Slivka AP. Early Loss of Cortical Density on Admission Computed Tomography Scan is Associated with Poor Pial Collaterals. Presented at the Annual Meeting of the American Society of Neuroradiology in Toronto, Canada. May 2005.
Mohammad YM, Christoforidis GA, Bourekas EC, Slivka AP. Relationship Between Severity of Arterial Occlusion and Early Ischemic Changes on Computed Tomographic Scan. Presented at the Annual Meeting of the American Society of Neuroradiology in Toronto, Canada. May 2005.
Stress and its relationship to stroke and cardiovascular diseases. American Heart Association/CTL Engineering. Columbus, Ohio. April 20th, 2005.
Update on Stroke Prevention. Berger Hospital. Circleville, Ohio. March 17th, 2005.
Mohammad YM, Christoforidis GA, Atieh JM, Slivka AP. Early Ischemic Changes on Admission Computed Tomography Scan is Associated with Larger Infarct Volume on Subsequent Computed Tomography Scan. Presented at the Annual Meeting of the American Society of Neuroimaging in Orlando, Florida. March 2005.
Mohammad YM, Christoforidis GA, Atieh JM, Bourekas EC, Slivka AP. Early Ischemic Changes on Admission Computed Tomography Scan is Associated with Poor Pial Collaterals. Presented at the Annual Meeting of the American Society of Neuroimaging in Orlando, Florida. March 2005.
Zaidat OO, Mohammad YM, Alexander MJ, Graffagnino C, Ionita C, Christoforidis GA, Slivka AP, Suarez JI. Intraarterial Thrombolytic Therapy in the Postcoronary Angiography Stroke. Presented at the 30th American Stroke Association International Stroke Conference in New Orleans, Louisiana. February 2-4, 2005.
Turan TN, Lynn M, Cotsonis G, Chaturvedi S, Chimowitz M, The WASID Trial Investigators. Presented at the 30th American Stroke Association International Stroke Conference in New Orleans, Louisiana. February 2-4, 2005.
Lynn M, Chimowitz M, Howlett-Smith H, Frankel M, Hertzberg V, Chaturvedi S, Kasner S, Levine S, Stern B, Benesch C, Jovin T, Sila C, Romano J, The WASID Trial Investigators. Presented at the 30th American Stroke Association International Stroke Conference in New Orleans, Louisiana. February 2-4, 2005.
Hankey GJ, for the VITATOPS Trail Collaborators. The VIITATOPS (VITAmins TO Prevent Stroke) Trial: Rationale, Design and Progress of an International, Large, Simple, Randomized Trial of Homocysteine-Lowering Multivitamin Therapy in Patients with Recent Transient Ischemic Attack or Stroke. Presented at the 30th American Stroke Association International Stroke Conference in New Orleans, Louisiana. February 2-4, 2005.
Saver JL, Carroll JD, Hijazi ZM, Larntz K, Veltum-Dockter K, The RESPECT Investigators. Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT) Trial. Presented at the 30th American Stroke Association International Stroke Conference in New Orleans, Louisiana. February 2-4, 2005.
Suri FK, Qureshi AI, Mohammad YM. Prehypertension Risk for Myocardial Infarction but not Ischemic Stroke. Presented at the 30th American Stroke Association International Stroke Conference in New Orleans, Louisiana. February 2-4, 2005.
Zaidat OO, Alexander MJ, Mohammad YM, Christoforidis GA, Ionita C, Graffagnino C, Smith TP, Suarez JI. Endovascular Intra-arterial Thrombolytic Therapy in the Post Cardiac Catheterization Stroke. Presented at the 8th Annual Joint Meeting of the American Society of Interventional Neuroradiology (ASITN) and the AANS/CNS Section on Cerebrovascular Surgery in New Orleans, Louisiana. February 2-4, 2005.
Meschia JF, Brott TG, Brown RD, Crook RJ, Kissela B, Brown WM, Rich SS, Case LD, Evans EW, Hague S, Singleton A, Hardy J, for the SWISS/ISGS/MSGD Investigators. Presented at the 30th American Stroke Association International Stroke Conference in New Orleans, Louisiana. February 2-4, 2005.
Christoforidis GA, Mohammad YM, Slivka AP, Slone W, Bourekas EC, Chakeres D. Operator Dependant Variability in Recanalization Rates Following Intra-arterial Thrombolysis. Presented at the 30th American Stroke Association International Stroke Conference in New Orleans, Louisiana. February 2-4, 2005.
Christoforidis GA, Mohammad YM, Slivka AP, Slone W, Bourekas EC, Chakeres D. Operator Dependant Variability in Recanalization Rates Following Intra-arterial Thrombolysis. Presented at the 8th Annual Joint Meeting of the American Society of Interventional Neuroradiology (ASITN) and the AANS/CNS Section on Cerebrovascular Surgery in New Orleans, Louisiana. February 2-4, 2005.
Christoforidis GA, Mohammad YM, Slivka AP. Arteriographic Demonstration of Slow Antegrade Opacification Distal to a Cerebrovascular Thromboembolic Occlusion Site as a Favorable Indicator for Intraarterial Thrombolysis. Presented at the 8th Annual Joint Meeting of the American Society of Interventional Neuroradiology (ASITN) and the AANS/CNS Section on Cerebrovascular Surgery in New Orleans, Louisiana. February 2-4, 2005.
Mohammad YM, Nasar A, Khatri, I. Congestive Heart Failure is Associated with Poor Outcome at 6 Months in Patients with Ischemic Stroke. Presented at the 30th American Stroke Association International Stroke Conference in New Orleans, Louisiana. February 2-4, 2005.
Mohammad YM, Christoforidis GA, Bourekas EC, Slivka AP. Prognostic Significance of Subcategories of Proximal Middle Cerebral Artery (M1) Occlusions Determined by the Qureshi Grading Scheme. Presented at the 8th Annual Joint Meeting of the American Society of Interventional Neuroradiology (ASITN) and the AANS/CNS Section on Cerebrovascular Surgery in New Orleans, Louisiana. February 2-4, 2005.
Stroke Prevention. Lancaster, Ohio. Nov. 11th, 2004.
Secondary Stroke Prevention . MedCentral Health System Hospital. Mansfield, Ohio. October 12th, 2004.
Secondary Stroke Prevention in 2005. Cuyahoga Falls, Ohio. October 12, 2005.
Emergency Management of Headache. As part of didactic lecture series to the Neurology residents at Ohio State University. Columbus, Ohio. Sept. 16th , 2004.
5. Management of Chronic Migraine Headache. Department of Family Medicine Ground Round at Ohio State University. Columbus, Ohio. Sept. 1st, 2004.
Secondary Stroke Prevention in 2004. Wright Patterson Air Force Base Hospital. Dayton, Ohio. August 19th, 2004.
Bourekas EC, Slivka AP, Shah R, Fetko N, Kogut M, Christoforidis GA, Mohammad YM, Slone W. Intra-arterial Thrombolysis for Stroke in Under 6 hours: One Institution’s Experience. Presented at the 42nd Annual Meeting of the American Society of Neuroradiology in Seattle, Washington June 5-11, 2004.
Christoforidis GA, Slivka A, Mohammad YM, Tejada A, Slone WH, Bourekas E, Chakeres D. Arteriographic Demonstration of Slow Antegrade Opacification Distal to a Cerebrovascular Thromboembolic Occlusion Site as a Favorable Indicator for Intraarterial Thrombolysis. Presented at the Annual Meeting of the American Society of Neuroradiology in Seattle, Washington June 5-11, 2004.
Christoforidis GA, Yang M, Mohammad YM, Abduljalil A, Heverhagen JT, Chakeres DW, Knopp MV. Imaging of Microvascularity During Acute Ischemic Stroke with and without Intravascular Contrast Agent on High-Resolution Ultra-High Field MRI in a Rodent Model with Histopathologic Correlation. Presented at the Annual Meeting of the American Society of Neuroradiology in Seattle, Washington June 5-11, 2004.
Christoforidis GA, Mohammad YM, Slivka A, Slone WH, Bourekas E, Chakeres DW. Is there a Difference in Clinical Outcome in Recanalizations Involving the Superior Division Versus the Inferior Division of the Middle Cerebral Artery? Presented at the Annual Meeting of the American Society of Neuroradiology in Seattle, Washington June 5-11, 2004.
Neuroanatomy Lectures as part of Basic Science Didactic lecture Series to the Neurology Residents at OSU. March 22nd, and 29th 2004. April19th 2004. May 3rd 2004.
Qureshi AI, Suri FK, Kirmani JF, Ahmed S, Mohammad YM, Divani AA. Retinal Vascular Disease Detected by Fundoscopy Can Identify Persons at Risk for Cardiovascular Diseases. Presented at the 56th Annual Meeting of the American Academy of Neurology in San Francisco, CA. April 24-May 1, 2004.
Chimowitz MI, Williams J, Stern BJ, Cotsonis G, Swanson S, Lynn M, Feldman E, the WASID Investigators. Physician Preferences for Diagnosis and Treatment of Symptomatic Intracranial (IC) Arterial Stenosis. Presened at the 56th Annual Meeting of the American Academy of Neurology in San Francisco, CA. April 24- May 1, 2004.
Mohammad YM, Qureshi AI, Suri FK, Kirmani JF, Divani AA, Ahmed S. Is Vaccination Protective for Caediovascular Disease in Middle Aged and Elderly Persons? Presented at the 56th Annual Meeting of the American Academy of Neurology in San Francisco, CA. April 24-May 1, 2004.
Christoforidis G, Mohammad YM, Bourekas EC, Slivka AP. Initial Severity of Angiographic Occlusion Predicts Subsequent Volume of Cerebral Infarction Following Intra-arterial Thrombolysis in Acute Ischemic Stroke. Presented at the 56th Annual Meeting of the American Academy of Neurology in San Francisco, Ca. April 24-May 1, 2004.
Bourekas EC, Slivka AP, Shah R, Triola CA, Kogut MJ, Fetko N, Christoforidis GA, Mohammad YM, Slone W. High Dose Recombinant Tissue Plasminogen Activator for the Intra-arterial Treatment of Stroke. Presented at the 7th Annual Joint Meeting of the American Society of Interventional Neuroradiology (ASITN) and the AANS/CNS Section on Cerebrovascular Surgery in San Diego, California. Feb. 2004.
Christoforidis GA, Mohammad YM, Bourekas EC, Slivka AP. Influence of Hemorrhage on Clinical Outcome Following Intra-arterial Thrombolytic Treatment. Presented at the 7th Annual Joint Meeting of the American Society of Interventional Neuroradiology (ASITN) and the AANS/CNS Section on Cerebrovascular Surgery in San Diego, California. Feb. 2004.
Mohammad YM, Kogut MJ, Slivka AP, Bourekas EC, Shah R, Christofiridis GA. Assessment of Recanalization with Intra-arterial Thrombolysis based on Stroke Etiology. Presented at the 7th Annual Joint Meeting of the American Society of Interventional Neuroradiology (ASITN) and the AANS/CNS Section on Cerebrovascular Surgery in San Diego, California. Feb. 2004.
Xavier AR, Mohammad YM, Christoforidis GA, Bourekas EC, Slivka AP. Can the Initial NIHSS Score Predict the Site and Severity of Arterial Occlusion in Patients with Acute Ischemic Stroke. Presented at the 7th Annual Joint Meeting of the American Society of Interventional Neuroradiology (ASITN) and the AANS/CNS Section on Cerebrovascular Surgery in San diego, California Feb. 2004.
Chimowitz M, Lynn M, Howlett-Smith H, Stern B, Hertzberg VS, Frankel M, Chaturvedi S, Kasner S, Benesch C, Sila C, Jovin T, Romano J, Levine SR, for the WASID Investigators. Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial: Final Results. Presented at the 29th American Stroke Association International Stroke Conference in San Diego, California. Feb. 2004.
Chimowitz M, Stern B, Frankel M, Chaturvedi S, Benesch C, Sila C, Jovin T, Levine SR, for the WASID Investigators. Preferences for Diagnosis and Treatment of Symptomatic Intracranial (IC) Stenosis. Presented at the 29th American Stroke Association International Stroke Conference in San Diego, California. Feb. 2004.
Williams JE, Hertzberg VS, Freret N, Swanson S, Cotsonis G, Chimowitz MI, for the WASID Study Group. Barriers to Recruitment in a Clinical Trial: Results from the Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Study. Presented at the 29th American Stroke Association International Stroke Conference in San Diego, California. Feb. 2004.
Christoforidis GA, Mohammad YM, Xavier AR, Bourekas EC, Slivka AP. Qureshi Grading Scheme for Angiographic Occlusions Strongly Correlates with the Post-Thrombolysis Infarction Volume in Patients with Acute Ischemic Stroke. Presented at the 7th Annual Joint Meeting American Society of Interventional Neuroradiology (ASITN) and the AANS/CNS Section on Cerebrovascular Surgery in San Diego, California. Feb 2004.
Mohammad YM, Qureshi AI, Suri MK, Xavier AR, Kirmani JF, Lynch JK. Is Pre-Hypertension a Risk Factor for Stroke and Myocardial Infarction? Presented at the 29th American Stroke Association International Stroke Conference in San Diego, California. Feb 2004.
Sawaki L, Butler AJ, Wassenaar P, Mohammad YM, Fowlkes A, Greenberg J, Nichols DS, Wolf SL, Good DC, Wittenberg GF. Motor Map Plasticity in Constraint for Stroke. Presented at the 29th American Stroke Association International Stroke Conference in San Diego, California. Feb 2004.
Mohammad YM, Bestic JM, Bourekas EC, Christoforidis GA, Slivka AP, Shah R. Good Clinical Outcome is Associated with Successful Recanalization from Intra-arterial Thrombolysis for Acute Ischemic Stroke. Presented at the 7th Annual Joint Meeting of the American Society of Interventional Neuroradiology (ASITN) and the AANS/CNS Section on Cerebrovascular Surgeryin San Diego, California. Feb 2004.
Medical Update: New Horizons in Diagnosis/Treating Stroke. Hospital Incentives for Primary Stroke Center Services. Toledo, Ohio. October 23, 2003.
Stroke Treatment and Prevention in 2003. VA Medical Center. Chillicothe, Ohio. September 25, 2003.
Neurology: Essential Topics for the Non-Neurologist. “Management of TIA: When to The ER? When to the Neurologist?”. The Ohio State University Hospitals East. Columbus, Ohio. September 12, 2003.
Christoforidis GA, Kehagias A, Slivka AP, Mohammad YM, Slone H, Bourekas EC, Baujan M, Chakeres D, Notestine P. Angiographic Assessment of Pial Collaterals as a Predictor of Infarct Volume Following Intra-Arterial Thrombolysis for M1 Segment Occlusions. Presented at the 41st American Society of Neuroradiology Annual Meeting in Washington, DC. April 26 – May 2, 2003.
Mohammad YM, Qureshi AI, Suri MK, Siddiqui AM, Kirmani JF, Xavier AR, Safdar A. Poorly Controlled Diabetes Mellitus ia a Risk Factor for Cognitive Impairment in the Elderly of United States. Presented at the 55th American Academy of Neurology Annual Meeting. Phoenix, Arizona. March 29 - April 5, 2003.
Ziai WC, Qureshi AI, Suri MK, Yahia AM, Mohammad YM, Sen S, Agarwal P, Zaidat OO, Suarez JI, Wityk RJ. Stroke-Free Survival and its Determinants in Patients with Symptomatic Vertebrobasilar Stenosis: A Multicenter Study. Presented at the 6th Annual Joint Meeting of the American Society of Interventional Neuroradiology (ASITN) and the AANS/CNS Section on Cerebrovascular Surgery in Phoenix, Arizona. Feb 2003.
Mohammad YM, Christoforidis G, Shah R, Slivka AP, Bourekas EC. Qureshi Grading System for Angiographic Evaluation of Arterial Occlusions Correlates with Severity of Ischemic Stroke. Presented at the 6th Annual Joint Meeting of the American Society of Interventional Neuroradiology (ASITN ) and the AANS/CNS Section on Cerebrovascular Surgery in Phoenix, Arizona. Feb 2003.
Christoforidis GA, Kehagias D, Mohammad YM, Notestine P, Shah R, Slone WH, Baujan M, Chakeres DW, Bourekas EC, Slivka AP. Angiographic Assessment of Pial Collaterals as a Prognostic Indicator Following Intra-Arterial Thrombolysis for Acute Ischemic Stroke. Presented at the 6th Annual Joint Meeting of the American Society of Interventional Neuroradiology (ASITN) and the AANS/CNS Section on Cerebrovascular Surgery in Phoenix, Arizona. Feb 2003.
Mohammad YM, Suri MK. Predictors and Rate of Stroke Recurrence in the First National Health and Nutrition Examination Follow-up Study. Presented at the 28th American Stroke Association International Stroke Conference in Phoenix, Arizona. Feb 2003.
Bourekas EC, Shah R, Christoforidis G, Mohammad YM, Suarez JI, Tarr RW, Landis DM, Slivka AP. Intra-Arterial Thrombolysis Therapy within Three Hours of Stroke Onset. Presented at the 28th American Stroke Association International Stroke Conference in Phoenix, Arizona. Feb 2003.
Qureshi AI, Mohammad YM, Yahia AM, Suarez JI, Siddiqui AM, Kirmani JF, Suri MK, Kolb J, Zaidat OO, Hopkins NL. A Prospective Multi-Center Study to Evaluate the Feasibility and Safety of Aggressive Anti-Hypertensive Treatment in Patients with Acute Intracerebral Hemorrhage. Presented at the 28th American Heart Association International Stroke Conference in Phoenix, Arizona. Feb 2003.
Bourekas EC, Shah R, Christoforidis G, Suarez JI, Mohammad YM, Slivka AP. Intra-arterial Thrombolytic Therapy Within Three Hours of Stroke Onset in Patients with Middle Cerebral Artery Occlusions. Presented at the 6th Annual Joint Meeting American Society of Interventional Neuroradiology (ASITN) and the AANS/CNS Section on Cerebrovascular Surgery in Phoenix, Arizona. Feb 2003.
Neurointervention in Acute Ischemic Stroke. Albany Medical college. Albany, New York. November 08, 2002.
Stroke Treatment and Prevention in 2002. Indian Community Doctors. Dayton, Ohio. June 19, 2002.
Perceptor for the third year medical students in the Introduction to Clinical Medicine Rotation at Ohio State University, Columbus, Ohio. June 2002.
Mohammad YM, Qureshi AI, Yahia AM, Zaidat O, Suarez JI, Ziai W, Wityk RJ, Agarwal P, Sen S, Thaler DE, Suri MK, Uzun G, Lieb AG, Martin TM. Stroke Free Survival and its Determinants in Patients with Symptomatic Vertebrobasilar Stenosis. Presented at the 54th Annual Meeting of the American Academy of Neurology in Denver, Colorado. April 2002.
Chaturvedi S, Lane B, Lynn M, Stern B, Chimowitz M, and the WASID Study Group. Prevalence and Treatment of Hypertension in Black and White Patients with Symptomatic Intracranial Atherosclerosis. Presented at the 54th Annual Meeting of the American Academy of Neurology in Denver, Colorado. April 2002.
Mohammad YM, Qureshi AI, Suri MK, Guterman LR, Hopkins NL. Impaired Glucose Tolerance and Risk of Fatal Stroke and Myocardial Infarction. Presented at the 27th American Heart Association International Stroke Conference in San Antonio, Texas. Feb 2002.
Pharmacological Treatment for Stroke Prevention. Updates on Anti-thrombotics, Ohio State University. Columbus, Ohio. Dec 2001.
Worrall BB, Johnston KC, Kongable G, Hung E, Leurgans S, Gorelick PB, for the AAASPS Investigators. Antihypertensive Use in Women and Men in the African-American Antiplatelet Stroke Prevention Study. Presented at the American Neurological Association, Boston, October 2000.
Rains J, Penzien D, Mohammad YM. Sleep and Headache: Morning Headache Associated with Sleep Disordered Breathing. Presented at the 10th Congress of the International Headache Society in New York, New York. June 2001.
Penzien D, Rains J, Andrew M, Mohammad YM, Mosley T. Relationships of Daily Stress, Sleep,and Headache: A Time Series Analysis. Presented at the 10th Congress of the International Headache Society in New York, New York. June 2001.
Penzien D, McCracken L, Rains JH, Mohammad YM. Examining Family and Marital Issues in Recurrent Headache Syndromes. Presented at the 10th Congress of the International Headache Society in New York, New York. June 2001.
Mohammad YM, Qureshi AI, Suri MK, Hopkins NL. Impact of Uncontrolled Hypertension on Stroke Occurrence in Survivors of Myocardial Infarction and Stroke. Presented at the 53rd American Academy of Neurology Annual Meeting in Philadelphia, Pennsylvania. May 2001.
Whittley CY, Raman R, Richardson D, Harris J, Gorelick PB, for the AAASPS Investigators. Are There Differences in Risk Factor Profiles and Frequency of CT/MRI-Based Infarcts Among African American Stroke Patients With and Without Hypertension? Presented at the 53rd American Academy of Neurology Annual Meeting in Philadelphia, Pennsylvania. May 2001.
Libman R, Kwiatkowski T, Stern B, Frankel M, Howlett-Smith H, Lynn M, Chimowitz. Clinical Profiles of Black and White Patients with Intracranial Arterial Stenosis: Preliminary Observations from WASID. Presented at the 53rd American Academy of Neurology Annual Meeting in Philadelphia, Pennsylvania. May 2001.
Penzien DB, Rains JC, Mohammad YM. Cost of Behavioral and Preventive Pharmacological Treatment for Recurrent Headache: Examination of Cumulative Financial Expense Over Time. Presented at the Society of Behavioral Medicine Annual Scientific Meeting in Seattle, Washington. March 2001.
Mohammad YM, Qureshi AI, Suri MK, Ali Z, Guterman LR, Hopkins NL. Isolated Systolic Hypertension and the long-term Risk of Stroke: A 20-Year follow-up of the National Health and Nutrition Survey. Presented at the 26th American Heart Association International Stroke Conference at Ft. Lauderdale, Florida. Feb 2001.
Uzun Guven, Qureshi AI, Mohammad YM, Zaidat O, Suarez JI, Suri MK, Ali Z, Lieb AG, Martin TM, Yahia AM, Guterman LR, Hopkins NL. Risk of Recurrent Ischemic Events In-Patients with Symptomatic Vertebro-Basilar Stenosis. Presented at the 26th American Heart Association International Stroke Conference at Ft. Lauderdale, Florida. Feb 2001.
Libman R, Kwiatkowski T, Stern B, Frankel M, Howlett-Smith H, Lynn M, Chimowitz M, for the WASID Study Group. Clinical Profiles of Black and White Patients with Intracranial Arterial Stenosis. Preliminary Observations from WASID. Presented at the 26th American Heart Association International Stroke Conference at Ft. Lauderdale, Florida. Feb 2001.
Chimowitz M, for the WASID Study Group. Prevalence of Extracranial Carotid Stenosis In-Patients with Symptomatic Intracranial Disease. Presented at the 26th American Heart Association International Stroke Conference at Ft. Lauderdale, Florida. Feb 2001.
Suarez JI, for the Massive Middle Cerebral Artery Infarction Review Group. Cardiovascular Complications in Patients with Massive Middle Cerebral Artery Infarction. Presented at the 26th American Heart Association International Stroke Conference at Ft. Lauderdale, Florida. Feb 2001.
Chaturvedi S, Raman R, Leurgans S, Gorelick PB, for the AAASPS Investigators. Are African American Stroke Patients Receiving Appropriate Carotid Ultrasound Exams? Presented at the 26th American Heart Association International Conference on Stroke and Cerebral Circulation at Fort Lauderdale, Florida. Feb 2001.
Lyden PD, for the CLASS I/H/T Investigators. Clomethiazole Acute Stroke-Study in Ischemic Stroke (CLASS-I): Efficacy Results in Patients with Major Acute Ischemic Stroke. Presented at the 26th American Heart Association International Conference on Stroke and Cerebral Circulation at Fort Lauderdale, Florida. Feb 2001.
Suarez JI, for the Massive Middle Cerebral Artery Infarction Review Group. Medical Complications in Patients with Massive Middle Cerebral Artery Infarction. Presented at the Annual Neuro-Critical Care Meeting at San Francisco, California. Feb 2001.
M Ekblom, Y-F Cheng, AstraZenca, Sodertalje, Sweden; M Jerling, Karolinska Inst, Huddinge, Sweden; M O Karlsson, Uppsala Univ, Uppsala, Sweden; N-G Wahlgren, Karolinska Hosp, Stochholm, Sweden; for the CLASS Study Group. Rationale for the Selection of the Dose of Zendra Used in the CLASS-I Study. Presented at the 26th American Heart Association International Conference on Stroke and Cerebral Circulation at Fort Lauderdale, Florida. Feb 2001.
Stroke Prevention and Treatment. Rush Foundation Hospital. Meridian, MS. November 09, 2000.
Stroke Prevention in 2000. West Jefferson Medical Center. Laurel, MS. October 19, 2000.
Secondary Stroke Prevention: The Role of Anti-lipids. Jackson, MS. October 17, 2000.
Uncommon Causes of Stroke. Stroke Update 2000. UMC Conference Center at Jackson Medical Mall in Jackson, MS. September 23, 2000.
Progress in Stroke Prevention and Treatment. Delta Regional Medical Center. Greenville, MS. July 14, 2000.
Secondary Stroke Prevention. Singing River Hospital. Pascagoula, MS. July 11, 2000.
Penzien DB, Rains JC, Mohammad YM. Tension-Type Headache Diagnosis Using the IHS Criteria: Characterization of Atypical Tension-Type (IHS 2.3) Patients. Presented at the American Headache Society Annual Meeting. Montreal, Canada, June 2000.
Mohammad YM, Qureshi AI, Suri MK, Guterman LR, Hopkins NL. Plasma Fibrinogen Levels and the Likelihood of Non-fatal Stroke and Myocardial Infarction: Data from the Third National Health and Nutrition Examination Survey. Presented at the 52nd American Academy of Neurology Annual Meeting, San Diego, April 2000.
Yahia AM, Qureshi AI, Suarez JI, Suri MK, Mohammad YM, Weityk R. Timing of Neurological Deterioration in Patients with Massive Middle Cerebral Artery Stroke. Presented at the 52nd American Academy of Neurology Annual Meeting, San Diego, April 2000.
Mohammad YM, Qureshi AI, Suri MF, Janardhan V, Braimah J, Frankel MR. Risk Factors for Intracerebral Hemorrhage in Young and Middle Aged African Americans. The Role of Cocaine Use and Hypertension. Presented at the 25th International Joint Conference on Stroke and Cerebral Circulation, New Orleans, Feb 2000.
Ksangha RM, Leurgans S, Hung E, Hessaballa H, Hsu C, Woo D, Choi J, Gorelick PB, for the AAASPS Investigators. Baseline Antihypertensive Medication Use in the African American Antiplatelet Stroke Prevention Study. Presented at the 25th American Heart Association International Conference on Stroke and Cerebral Circulation, New Orleans, Feb 2000.
Annual Lectures to the Neurology Residents, as part of Didactic Lecture Series, at the University of Mississippi Medical Center. Topics: Stroke Syndromes, Stroke Treatment, and Prevention
Quarterly Neuro Exam lecture to the second-year Independent Study Program Students at Ohio State University.

Awards:

2007 Best Doctors in America®
Christoforidis GA, Yang M, Mohammad YM, Slivka AP. Effect of Hypercarbia on Infarct Volume in Experimental Stroke. Received Poster Award at the Ninth Joint Annual Meeting of the AANS/CNS Cerebrovascular Section and the ASITN. February 17-20, 2006
Excellence in Care Award, the Vascular Disease Foundation, for Outstanding Vascular Patient Care and Leadership in Vascular Disease Education and Awareness. November 29, 2005
Nominated by the Carl G Evers, M.D. Society, at the University of Mississippi Medical Center, for the Clinical Science Professor of the Year Award in 2001.